- Home
- LOGC vs ALEC Comparison
LOGC vs ALEC Comparison
Compare LOGC & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOGC
- ALEC
- Stock Information
- Founded
- LOGC 2010
- ALEC 2013
- Country
- LOGC United States
- ALEC United States
- Employees
- LOGC 400
- ALEC N/A
- Industry
- LOGC Catalog/Specialty Distribution
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LOGC Consumer Discretionary
- ALEC Health Care
- Exchange
- LOGC Nasdaq
- ALEC Nasdaq
- Market Cap
- LOGC 185.5M
- ALEC 101.1M
- IPO Year
- LOGC 2020
- ALEC 2019
- Fundamental
- Price
- LOGC $7.38
- ALEC $1.04
- Analyst Decision
- LOGC
- ALEC Buy
- Analyst Count
- LOGC 0
- ALEC 7
- Target Price
- LOGC N/A
- ALEC $4.10
- AVG Volume (30 Days)
- LOGC 299.3K
- ALEC 903.5K
- Earning Date
- LOGC 05-09-2025
- ALEC 05-16-2025
- Dividend Yield
- LOGC N/A
- ALEC N/A
- EPS Growth
- LOGC N/A
- ALEC N/A
- EPS
- LOGC N/A
- ALEC N/A
- Revenue
- LOGC $43,000,000.00
- ALEC $100,558,000.00
- Revenue This Year
- LOGC $433.37
- ALEC N/A
- Revenue Next Year
- LOGC N/A
- ALEC $376.51
- P/E Ratio
- LOGC N/A
- ALEC N/A
- Revenue Growth
- LOGC N/A
- ALEC 3.60
- 52 Week Low
- LOGC $4.92
- ALEC $0.87
- 52 Week High
- LOGC $9.34
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- LOGC 59.69
- ALEC 43.22
- Support Level
- LOGC $6.84
- ALEC $1.07
- Resistance Level
- LOGC $7.32
- ALEC $1.34
- Average True Range (ATR)
- LOGC 0.26
- ALEC 0.10
- MACD
- LOGC 0.05
- ALEC 0.01
- Stochastic Oscillator
- LOGC 89.02
- ALEC 31.19
About LOGC ContextLogic Inc.
ContextLogic Inc is an online shopping store. The store provides personalized products, clothing products, accessories, gaming products and equipment, cosmetics, plastic products, mobile covers, and other products. Geographically, it derives majority of its revenue from Europe and also has a presence in North America; South America, and other countries.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.